Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exubera in Poorly Controlled Type 2 Diabetes
NCT00282971Phase 3Terminated
- Sponsor
- Pfizer
- Start
- Mar 2006
- Primary completion
- Feb 2008
- Modality
- Biologic
- Countries
- 7
01
Overview
A Phase 3 trial of insulin human in type 2 diabetes mellitus (T2DM), sponsored by Pfizer. Started Mar 2006; status: terminated.
02
Drugs
insulin human
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00282971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00282971.